Veeva Systems Inc. $VEEV Shares Sold by Baer Investment Advisory LLC

Baer Investment Advisory LLC lowered its position in shares of Veeva Systems Inc. (NYSE:VEEV) by 4.0% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 14,341 shares of the technology company’s stock after selling 593 shares during the period. Veeva Systems makes up approximately 6.2% of Baer Investment Advisory LLC’s portfolio, making the stock its 4th largest position. Baer Investment Advisory LLC’s holdings in Veeva Systems were worth $4,332,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Crossmark Global Holdings Inc. acquired a new stake in shares of Veeva Systems during the 1st quarter worth approximately $299,000. GAMMA Investing LLC increased its holdings in shares of Veeva Systems by 13.8% during the 1st quarter. GAMMA Investing LLC now owns 1,823 shares of the technology company’s stock worth $422,000 after buying an additional 221 shares during the last quarter. Private Trust Co. NA increased its holdings in shares of Veeva Systems by 35.0% during the 1st quarter. Private Trust Co. NA now owns 247 shares of the technology company’s stock worth $57,000 after buying an additional 64 shares during the last quarter. Merit Financial Group LLC increased its holdings in shares of Veeva Systems by 12.5% during the 2nd quarter. Merit Financial Group LLC now owns 45,247 shares of the technology company’s stock worth $13,030,000 after buying an additional 5,042 shares during the last quarter. Finally, QRG Capital Management Inc. increased its holdings in shares of Veeva Systems by 15.7% during the 2nd quarter. QRG Capital Management Inc. now owns 12,771 shares of the technology company’s stock worth $3,678,000 after buying an additional 1,735 shares during the last quarter. Institutional investors and hedge funds own 88.20% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on VEEV. KeyCorp raised their price target on shares of Veeva Systems from $285.00 to $325.00 and gave the stock an “overweight” rating in a report on Monday, July 14th. Raymond James Financial reaffirmed an “outperform” rating and set a $340.00 price objective (up previously from $310.00) on shares of Veeva Systems in a research report on Thursday, August 28th. BTIG Research reaffirmed a “buy” rating and set a $340.00 price objective on shares of Veeva Systems in a research report on Friday, October 17th. TD Cowen raised shares of Veeva Systems from a “hold” rating to a “buy” rating and increased their price objective for the stock from $297.00 to $380.00 in a research report on Tuesday, October 7th. Finally, Citigroup increased their price objective on shares of Veeva Systems from $329.00 to $349.00 and gave the stock a “buy” rating in a research report on Thursday, August 28th. Seventeen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $307.58.

Insider Buying and Selling at Veeva Systems

In other Veeva Systems news, insider Eleni Nitsa Zuppas sold 6,000 shares of the firm’s stock in a transaction that occurred on Tuesday, October 7th. The shares were sold at an average price of $306.62, for a total value of $1,839,720.00. Following the completion of the transaction, the insider owned 25,325 shares of the company’s stock, valued at $7,765,151.50. This trade represents a 19.15% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, SVP Jonathan Faddis sold 14,595 shares of the firm’s stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $300.00, for a total transaction of $4,378,500.00. Following the completion of the transaction, the senior vice president directly owned 8,588 shares of the company’s stock, valued at $2,576,400. This represents a 62.96% decrease in their position. The disclosure for this sale can be found here. Insiders sold 24,665 shares of company stock valued at $7,438,000 in the last 90 days. Company insiders own 10.30% of the company’s stock.

Veeva Systems Stock Up 0.6%

Shares of VEEV stock opened at $293.11 on Monday. Veeva Systems Inc. has a 52 week low of $201.54 and a 52 week high of $310.50. The stock has a market capitalization of $48.04 billion, a PE ratio of 60.19, a P/E/G ratio of 2.26 and a beta of 0.98. The firm has a 50 day moving average of $284.70 and a two-hundred day moving average of $270.03.

Veeva Systems (NYSE:VEEV) last issued its quarterly earnings results on Wednesday, August 27th. The technology company reported $1.26 EPS for the quarter, missing the consensus estimate of $1.90 by ($0.64). Veeva Systems had a net margin of 27.29% and a return on equity of 13.72%. The business had revenue of $789.08 million during the quarter, compared to analysts’ expectations of $768.49 million. During the same period in the prior year, the business earned $1.62 EPS. The business’s quarterly revenue was up 16.7% on a year-over-year basis. Veeva Systems has set its Q3 2026 guidance at 1.940-1.950 EPS. FY 2026 guidance at 7.780-7.780 EPS. Analysts expect that Veeva Systems Inc. will post 4.35 EPS for the current fiscal year.

About Veeva Systems

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.